Breast Cancer,TNBC (Triple Negative Breast Cancer) Toripalimab Plus Metronomic Chemotherapy in MBC Jan 29, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Correlation of mIF and Gene Expression in HER2+ BC Cohort Jan 24, 2024
Breast Cancer,Colorectal Cancer,Gastrointestinal Cancer,Gynecologic Cancer,TNBC (Triple Negative Breast Cancer),Uterine Cancer BDC-1001 ISAC Monotherapy + Nivolumab in Solid Tumors Jan 24, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Avelumab Boosts PFS in Heavily Pretreated HER2+ MBC Jan 24, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) RIB + NSAI in HR+/HER2−Early BC: NATALEE Trial iDFS Jan 22, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) HER2-Low in Early BC: Clinical Insights From PALLAS Trial Jan 19, 2024
Breast Cancer,HER2- Camizestrant Study: Tailored Pre-surgical ER+ Breast Cancer Treatment Jan 18, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Efficacy of Durvalumab With Neoadjuvant Chemotherapy in BC Jan 17, 2024